Genotex International (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 9.00 M
as on 05-07-2024
- Company Age 22 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 Cr
as on 05-07-2024
- Satisfied Charges ₹ 8.15 Cr
as on 05-07-2024
- Revenue -12.31%
(FY 2022)
- Profit 0.40%
(FY 2022)
- Ebitda -518.41%
(FY 2022)
- Net Worth 5.23%
(FY 2022)
- Total Assets -2.27%
(FY 2022)
About Genotex International (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹6.30 Cr. The company has closed loans amounting to ₹8.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Thara Chintalapani, Rahul Chinthalapani, and Deepa Dammanagari serve as directors at the Company.
- CIN/LLPIN
U24239TG2002PTC038777
- Company No.
038777
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Genotex International (India) Private Limited offer?
Genotex International (India) Private Limited offers a wide range of products and services, including Salon, Spa Kits & Equipments, Shaving Accessories, Bath Tools, Body Washes, Herbal Capsules, Aloe Vera Capsules, Hair Shampoo, Aloe Vera Shampoo, Herbal Powder, Amla Powder.
Who are the key members and board of directors at Genotex International (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thara Chintalapani  | Director | 10-Apr-2002 | Current |
| Rahul Chinthalapani | Director | 23-Feb-2019 | Current |
| Deepa Dammanagari | Additional Director | 04-Mar-2024 | Current |
Financial Performance of Genotex International (India).
Genotex International (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.31% decrease. The company also saw a slight improvement in profitability, with a 0.4% increase in profit. The company's net worth moved up by a moderate rise of 5.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genotex International (India)?
In 2022, Genotex International (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Mar 2024 | ₹6.30 Cr | Open |
Uco Bank Creation Date: 24 Nov 2022 | ₹2.60 Cr | Satisfied |
Uco Bank Creation Date: 16 Aug 2021 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Genotex International (India)?
Unlock and access historical data on people associated with Genotex International (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genotex International (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genotex International (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
